NLS PHARMACEUTICS LTD (NLSP) Stock Overview
USA - NASDAQ:NLSP - CH1384053976 - Common Stock
NLSP Key Statistics, Chart & Performance
The current stock price of NLSP is 1.3 USD. In the past month the price decreased by -40.64%. In the past year, price decreased by -68.9%.
NLSP Latest News, Press Relases and Analysis
NLSP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.11 | 781.26B | ||
| JNJ | JOHNSON & JOHNSON | 18.34 | 458.55B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.76 | 258.24B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.73 | 252.36B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.65 | 235.32B | ||
| MRK | MERCK & CO. INC. | 11.36 | 218.53B | ||
| PFE | PFIZER INC | 7.3 | 140.77B | ||
| SNY | SANOFI-ADR | 11.74 | 125.85B | ||
| GSK | GSK PLC-SPON ADR | 9.65 | 86.97B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.51 | 89.21B | ||
| ZTS | ZOETIS INC | 23.46 | 64.68B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.04 | 44.25B |
Related stock screener links
About NLSP
Company Profile
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
Company Info
NLS PHARMACEUTICS LTD
The Circle 6
Zurich ZUERICH CH-6370 CH
CEO: Alexander Zwyer
Employees: 7
Phone: 41445122150
NLS PHARMACEUTICS LTD / NLSP FAQ
What does NLSP do?
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
What is the current price of NLSP stock?
The current stock price of NLSP is 1.3 USD. The price decreased by -1.52% in the last trading session.
What is the dividend status of NLS PHARMACEUTICS LTD?
NLSP does not pay a dividend.
What is the ChartMill technical and fundamental rating of NLSP stock?
NLSP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is NLS PHARMACEUTICS LTD worth?
NLS PHARMACEUTICS LTD (NLSP) has a market capitalization of 7.79M USD. This makes NLSP a Nano Cap stock.
NLSP Technical Analysis
NLSP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NLSP. NLSP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NLSP Financial Highlights
Over the last trailing twelve months NLSP reported a non-GAAP Earnings per Share(EPS) of -2.93. The EPS increased by 77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -181.68% | ||
| ROE | -288.47% | ||
| Debt/Equity | 0 |